SCHEMBL7709100

SCHEMBL7709100

CCOC(=O)Cn1nc(S(=O)(=O)Cc2ccc(F)cc2)c2ccc(F)cc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.51
NPSR1 Q6W5P4 3/20 0.51
POLB P06746 2/20 0.47
HCRTR1 O43613 2/20 0.45
HCRTR2 O43614 2/20 0.45
LMNA P02545 2/20 0.44
GAA P10253 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
PTGS2 P35354 1/20 0.41
ALDH1A1 P00352 2/20 0.41
HK1 P19367 1/20 0.41
HKDC1 Q2TB90 1/20 0.41
PPARG P37231 1/20 0.41
MAPK8 P45983 1/20 0.37
PKM P14618 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7707974 0.94 HCRTR2 (0.53) SMN1; SMN2NPSR1POLBHCRTR1HCRTR2
SCHEMBL7704817 0.91 SMN1; SMN2 (0.55) SMN1; SMN2NPSR1POLBHCRTR1HCRTR2
SCHEMBL7702319 0.85 HCRTR2 (0.47) SMN1; SMN2NPSR1POLBHCRTR1HCRTR2
SCHEMBL2588992 0.83 HCRTR2 (0.44) SMN1; SMN2NPSR1POLBHCRTR1HCRTR2
SCHEMBL7708409 0.81 HCRTR1 (0.68) SMN1; SMN2NPSR1HCRTR1HCRTR2LMNA
SCHEMBL7713640 0.79 HCRTR2 (0.54) POLBHCRTR1HCRTR2
SCHEMBL2592050 0.78 THRB (0.46) POLBHCRTR1HCRTR2PKM
SCHEMBL7712435 0.77 HCRTR2 (0.48) HCRTR1HCRTR2GAA
SCHEMBL2595050 0.77 HCRTR2 (0.53) SMN1; SMN2NPSR1POLBHCRTR1HCRTR2
SCHEMBL7702650 0.77 HCRTR2 (0.78) SMN1; SMN2POLBHCRTR1HCRTR2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011138265-A2 INDOLE AND INDAZOLE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS EVOTEC AG (DE) 2011-11-10 WO disclosed